Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare ...
Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Zimmer Biomet (ZBH) to $107 from $115 and keeps a Hold rating on the ...
The S&P 500 Dividend Aristocrats Index pairs long-term results with versatility. We sell different types of products and services to both investment professionals and individual investors. These ...
WARSAW, Ind., Jan. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results